BridgeBio Oncology Therapeutics (BBOT)
0 followers
‌
BridgeBio Oncology Therapeutics is a clinical-stage biopharmaceutical company advancing a next generation pipeline of novel small molecule therapeutics targeting RAS and PI3K malignancies. Initially formed as a subsidiary of BridgeBio, BridgeBio Oncology Therapeutics completed a $200M private financ... Read more
Industries
+1
Headquarters
Employees
Links
Org chart
Eli Wallace
Chief Executive Officer
Eli Wallace
Collapse
Pedro J. Beltran
Chief Scientific Officer
Howard Chang
Vice President, Operations
Raymond Kelleher
Director
Scott Platshon
Board Observer
